Alex CheesmanDecember 18, 2024
In a groundbreaking effort to make clinical trials more accessible for patients with rare diseases, mdgroup successfully conducted mobile health visits for two brothers in Tel Aviv, Israel, diagnosed with…
Read More 
Alex CheesmanAugust 14, 2024
The patientprimary team have hit another patient engagement milestone by assisting a patient from a small town on the Island country of Bahrain. This Island off the coast of West Asia,…
Read More
Alex CheesmanMay 15, 2024
The Challenge mdgroup supported a groundbreaking initiative in paediatric clinical trials, focusing on children with SCN2A-DEE and SCN8A-DEE, which causes a range of neurological conditions, including severe early-onset epilepsies, encephalopathies,…
Read More
Alex CheesmanApril 8, 2024
mdgroup is currently supporting a global study on the rare disease Amyotropic Lateral Sclerosis (ALS), a nervous system disease that affects nerve cells in the brain and spinal cord. We…
Read More
Alex CheesmanApril 5, 2024
A global CRO faced a daunting challenge in managing a clinical research site, known for its staffing shortages and difficult working conditions.
Read More
mdgroup SupportApril 27, 2023
Overcoming cultural, geographical, and financial barriers to facilitate a life-changing trial for one of the world’s rarest diseases The Challenge A very young patient had the opportunity to participate in…
Read More
mdgroup SupportMarch 8, 2023
The Challenge mdgroup recently supported a single ascending dose hybrid clinical trial, which investigated ways to correct the problem in protein transcription in the gene overexpression of Friedrich's Ataxia, an…
Read More
mdgroup SupportDecember 14, 2022
Facilitating remarkable patient experiences and removing the burden of site participation. The Challenge A young patient had the opportunity to participate in a clinical study into Danon disease, a rare…
Read More